AASLD 2015: Sofosbuvir/ Ledipasvir + Vedroprevir Cures 96% of Cirrhotic Genotype 1 Patients

Press/Media: Press / Media

PeriodNov 17 2015

Media coverage

1

Media coverage

  • TitleAASLD 2015: Sofosbuvir/ Ledipasvir + Vedroprevir Cures 96% of Cirrhotic Genotype 1 Patients
    Media name/outletHIV and Hepatitis.com
    CountryUnited States
    Date11/17/15
    PersonsEric J Lawitz